-
2
-
-
6344286003
-
Delayed immunologic thrombocytopenia induced by abciximab
-
Nurden P, Clofent-Sanchez G, Jais C, Bermejo E, Leroux L, Coste P, Nurden AT. Delayed immunologic thrombocytopenia induced by abciximab. Thromb Haemost 2004; 92: 820-8.
-
(2004)
Thromb Haemost
, vol.92
, pp. 820-828
-
-
Nurden, P.1
Clofent-Sanchez, G.2
Jais, C.3
Bermejo, E.4
Leroux, L.5
Coste, P.6
Nurden, A.T.7
-
3
-
-
33646016570
-
The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors
-
Aster RH, Curtis BR, Bougie DW, Dunkley S, Greinacher A, Warkentin TE, Chong BH. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost 2006; 4: 678-9.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 678-679
-
-
Aster, R.H.1
Curtis, B.R.2
Bougie, D.W.3
Dunkley, S.4
Greinacher, A.5
Warkentin, T.E.6
Chong, B.H.7
-
4
-
-
0037105428
-
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa
-
Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002; 100: 2071-6.
-
(2002)
Blood
, vol.100
, pp. 2071-2076
-
-
Bougie, D.W.1
Wilker, P.R.2
Wuitschick, E.D.3
Curtis, B.R.4
Malik, M.5
Levine, S.6
Lind, R.N.7
Pereira, J.8
Aster, R.H.9
-
5
-
-
0037093079
-
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated
-
Billheimer JT, Dicker IB, Wynn R, Bradley JD, Cromley DA, Godonis HE, Grimminger LC, He B, Kieras CJ, Pedicord DL, Spitz SM, Thomas BE, Zolotarjova NI, Gorko MA, Hollis GF, Daly RN, Stern AM, Seiffert D. Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated. Blood 2002; 99: 3540-6.
-
(2002)
Blood
, vol.99
, pp. 3540-3546
-
-
Billheimer, J.T.1
Dicker, I.B.2
Wynn, R.3
Bradley, J.D.4
Cromley, D.A.5
Godonis, H.E.6
Grimminger, L.C.7
He, B.8
Kieras, C.J.9
Pedicord, D.L.10
Spitz, S.M.11
Thomas, B.E.12
Zolotarjova, N.I.13
Gorko, M.A.14
Hollis, G.F.15
Daly, R.N.16
Stern, A.M.17
Seiffert, D.18
-
6
-
-
2442570825
-
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting
-
Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation 2004; 109: 2203-6.
-
(2004)
Circulation
, vol.109
, pp. 2203-2206
-
-
Merlini, P.A.1
Rossi, M.2
Menozzi, A.3
Buratti, S.4
Brennan, D.M.5
Moliterno, D.J.6
Topol, E.J.7
Ardissino, D.8
-
7
-
-
0037222079
-
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: Implications for the etiology of thrombocytopenia
-
Seiffert D, Stern AM, Ebling W, Rossi RJ, Barrett YC, Wynn R, Hollis GF, He B, Kieras CJ, Pedicord DL, Cromley DA, Hua TA, Stein RB, Daly RN, Sferruzza A, Pieniaszek HJ, Billheimer JT. Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: Implications for the etiology of thrombocytopenia. Blood 2003; 101: 58-63.
-
(2003)
Blood
, vol.101
, pp. 58-63
-
-
Seiffert, D.1
Stern, A.M.2
Ebling, W.3
Rossi, R.J.4
Barrett, Y.C.5
Wynn, R.6
Hollis, G.F.7
He, B.8
Kieras, C.J.9
Pedicord, D.L.10
Cromley, D.A.11
Hua, T.A.12
Stein, R.B.13
Daly, R.N.14
Sferruzza, A.15
Pieniaszek, H.J.16
Billheimer, J.T.17
-
8
-
-
6344274868
-
Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug
-
Curtis BR, Divgi A, Garrity T, Aster RH. Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2004; 2: 985-92.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 985-992
-
-
Curtis, B.R.1
Divgi, A.2
Garrity, T.3
Aster, R.H.4
-
9
-
-
23844531640
-
Delayed tirofiban-induced thrombocytopenia: Two case reports
-
Bosco A, Kidson-Gerber G, Dunkley S. Delayed tirofiban-induced thrombocytopenia: Two case reports. J Thromb Haemost 2005; 3: 1109-10.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1109-1110
-
-
Bosco, A.1
Kidson-Gerber, G.2
Dunkley, S.3
-
10
-
-
30944449768
-
Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events
-
Dunkley S, Evans S, Gaudry L, Jepson N. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events. Platelets 2005; 16: 462-8.
-
(2005)
Platelets
, vol.16
, pp. 462-468
-
-
Dunkley, S.1
Evans, S.2
Gaudry, L.3
Jepson, N.4
-
11
-
-
33746638332
-
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by anti-platelet GPIIb-IIIa vs. GPIbα antibodies
-
Webster ML, Sayeh E, Crow M, Chen P, Nieswandt B, Freedman J, Ni H. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by anti-platelet GPIIb-IIIa vs. GPIbα antibodies. Blood 2006; 108: 943-6.
-
(2006)
Blood
, vol.108
, pp. 943-946
-
-
Webster, M.L.1
Sayeh, E.2
Crow, M.3
Chen, P.4
Nieswandt, B.5
Freedman, J.6
Ni, H.7
-
12
-
-
33644701024
-
Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia
-
Dorsch MP, Montague D, Rodgers JE, Patterson C. Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia. Pharmacotherapy 2006; 26: 423-7.
-
(2006)
Pharmacotherapy
, vol.26
, pp. 423-427
-
-
Dorsch, M.P.1
Montague, D.2
Rodgers, J.E.3
Patterson, C.4
|